How well does this migraine medication work in real-world settings

This trial is testing how well ubrogepant works when people use it early during a migraine attack—specifically during the prodrome phase, which is when warning symptoms first appear. Researchers want to understand whether taking the medication at this early stage helps reduce how severe the migraine becomes. The study will follow about 189 adults across the United States for up to 13 weeks.

Many people with migraines struggle to manage their attacks effectively. By studying whether this medication works better when taken very early—right when warning signs appear—doctors hope to find a better way to help patients stop migraines before they become severe.